Share This Page
List of Excipients in Branded Drug COLGATE
✉ Email this page to a colleague
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Colgate-Palmolive Company | COLGATE | sodium fluoride and triclosan | 35000-003 | CARBOXYMETHYLCELLULOSE SODIUM | |
| Colgate-Palmolive Company | COLGATE | sodium fluoride and triclosan | 35000-003 | CARRAGEENAN | |
| Colgate-Palmolive Company | COLGATE | sodium fluoride and triclosan | 35000-003 | GLYCERIN | |
| Colgate-Palmolive Company | COLGATE | sodium fluoride and triclosan | 35000-003 | HYDRATED SILICA | |
| Colgate-Palmolive Company | COLGATE | sodium fluoride and triclosan | 35000-003 | PROPYLENE GLYCOL | |
| Colgate-Palmolive Company | COLGATE | sodium fluoride and triclosan | 35000-003 | SACCHARIN SODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipient Strategy and Commercial Opportunities for Colgate: What Formulation Makers Can Win With
Executive summary
Colgate is a consumer-health brand with prescription-style complexity only insofar as it uses regulated active ingredients and claims on regulated product types (notably mouth care and, in some markets, therapeutic dental products). For “excipient strategy,” the commercial opportunity is driven less by patentable core chemistry and more by: (1) regulatory-compliant stability and bioavailability of actives in complex aqueous systems, (2) cost and supply resilience of gums/surfactants/solubilizers/humectants, (3) reformulation pathways that reduce minor component risk (sensitizers, impurities, microbial control), and (4) route-to-market speed for private label and contract manufacturing.
What matters commercially: excipient-driven product differentiation (texture, foam, flavor release, remineralization support, plaque control claims), shelf-life and microbial stability, and manufacturing robustness that reduces line downtime and batch failures.
No defensible, company-specific patent/exclusivity map is produced here because “COLGATE” is not a single drug product with an identifiable active ingredient, strength, dosage form, and FDA/EMA authorization record that can be tied to an Orange Book-style or EMA-style exclusivity/patent estate.
What excipients does Colgate typically rely on, and which ones control performance?
Featured snippet: Colgate mouth-care products are formulated around humectants (water-binding), polishing abrasives (cleaning and stain control), surfactants (wetting and foam), binders/thickeners (rheology), fluoride-compatible calcium management systems, sweeteners and flavor carriers, and preservatives plus antimicrobial control to prevent microbial growth.
Core excipient categories and their functional levers
-
Humectants
- Examples: glycerin, sorbitol, propylene glycol.
- Commercial role: controls water activity for shelf life and taste perception, reduces drying in gel systems, supports viscosity stability.
-
Abrasives / polishing agents
- Examples (varies by product): hydrated silica, calcium carbonate, dicalcium phosphate.
- Commercial role: controls cleaning feel, viscosity-in-use, suspension stability, and compatibility with fluoride and anti-caries actives.
-
Thickeners, binders, and rheology modifiers
- Examples: carbomer, cellulose derivatives (e.g., CMC), xanthan gum, SEP-type emulsifiers in some systems.
- Commercial role: prevents abrasive settling, improves spreadability, supports consistent dosing and consumer texture.
-
Surfactants and wetting agents
- Examples: sodium lauryl sulfate (in some formulas), cocamidopropyl betaine, PEG-based solubilizers depending on product class.
- Commercial role: determines foam and mouthfeel, wetting of gums and oral surfaces, and flavor dispersion.
-
Flavor systems and sweeteners
- Examples: menthol, essential oils, saccharin or sucralose, flavor carriers.
- Commercial role: flavor release kinetics and sensory masking of actives and abrasives; risk management for allergen declarations in certain jurisdictions.
-
Preservatives / antimicrobial control
- Examples: benzoates, phenoxyethanol, other approved preservatives depending on region.
- Commercial role: microbial safety and shelf-life; interacts with pH and surfactant systems.
-
Chelators, pH adjusters, and buffering agents
- Examples: citrates, phosphates, sodium hydroxide, acids.
- Commercial role: stable ion environment, especially in fluoride systems where calcium/phosphate interactions can reduce availability.
Which excipients most often determine commercial differentiation
- Rheology package (thickener + binder + abrasive dispersion): drives “spread,” “slip,” and consumer repeat purchase.
- Fluoride compatibility management (buffering + chelator + abrasive chemistry): drives caries-control claims and reduces “lost fluoride” behavior from mineral interactions.
- Suspension stability (particle size control + polymer adsorption): reduces settle-out at retail ends and during temperature swings.
- Sensory system (humectant ratio + flavor release): influences perceived mildness and “freshness.”
How do excipients impact stability and active ingredient performance in toothpaste and oral gels?
Featured snippet: Stability problems in Colgate-type mouth-care formulas commonly come from abrasive sedimentation, pH drift, surfactant phase separation, flavor oil loss, microbial growth, and fluoride inactivation from mineral interactions.
Stability risk map for mouth-care formulations
| Risk driver | Typical excipient involvement | Failure mode | Commercial impact |
|---|---|---|---|
| Abrasive settling | Thickeners, polymer dispersants, particle surface chemistry | grit at bottom, poor dosing | retailer returns, complaint risk |
| Fluoride availability loss | buffers, chelators, calcium/phosphate balance, abrasive choice | reduced anticaries performance | claim underperformance in consumer tests |
| Phase instability | surfactants + solubilizers | separation, viscosity swings | shelf-life reduction, line stoppages |
| Flavor drop-out | flavor solubilizers, hydrophobic components | off-notes, uneven taste | reformulation cycles |
| Microbial contamination | preservatives, water activity control | safety risk, recalls | regulatory and brand damage |
Manufacturing robustness
- Excipient interactions can change mixing viscosity, required shear, and pumpability.
- Polymer adsorption onto abrasive surfaces can shift dispersion kinetics and affect throughput.
- Salt and pH changes can alter surfactant micelle behavior, causing batch-to-batch variation.
Which excipient reforms create the fastest commercial opportunities for Colgate-adjacent products?
Featured snippet: Fastest opportunities are excipient substitutions that improve stability, reduce cost or supply risk, and meet evolving regulatory/sustainability expectations without changing the active claim package.
Opportunity areas
-
Cost-down excipient swaps
- Replace higher-cost polymers with equivalent rheology alternatives that keep abrasive suspension stable.
- Reduce expensive dispersion aids by optimizing abrasive surface treatment and polymer adsorption.
-
Supply-chain risk reduction
- Dual-source humectants and stabilizers.
- Reduce dependence on single surfactant families by qualifying alternatives that maintain foam and wetting.
-
Regulatory harmonization
- Optimize preservative packages to meet regional requirements on allowed agents and labeling.
- Improve impurity control (nitrosamines, 1,4-dioxane where applicable for certain manufacturing routes of glycols or ethoxylates).
-
Sensory upgrades
- Adjust humectant blends to reduce aftertaste.
- Rebuild flavor solubilization to maintain “fresh burst” through shelf life.
Commercial positioning plays
- Premium texture claims: improved spreadability, reduced “grit,” less foam collapse.
- Sensitivity-focused products: excipient choices that reduce irritancy and preserve comfort in use.
- Whitening and stain-control: abrasive type and polymer dispersants to maximize perceived cleanliness while controlling abrasive abrasivity and suspension stability.
What formulation strategies protect “performance” when excipient patents are weak?
Featured snippet: In mouth care, many “best-in-class” benefits come from formulation architecture and process control, not from long-lived excipient IP. The defensible angle is manufacturing know-how: dispersion control, particle surface conditioning, viscosity ramps, and in-process QA thresholds.
Defensibility levers
-
Process controls
- Mixing order and time to achieve consistent polymer adsorption.
- Shear rate windows that keep abrasive dispersion stable.
-
Specification tightening
- Narrow tolerances on viscosity at temperature, sedimentation rate, particle size distribution.
- Flavor oil droplet size or solubilization indicator testing.
-
Microbial control
- Water activity target ranges.
- Preservative efficacy testing by region and pack type.
-
Compatibility design
- Fluoride stability testing under simulated shelf and thermal cycling.
- Ion balance formulation that protects anticaries performance.
How does an excipient strategy affect regulatory pathway and product claims for Colgate-type products?
Featured snippet: For non-prescription mouth-care products, excipient changes still require verification that the finished product remains within approved specification and continues to meet claim substantiation requirements. For therapeutic or medicinal variants (where applicable), the regulatory scrutiny increases.
Claim substantiation dependencies
- Caries control claims correlate with fluoride bioavailability and stability.
- Whitening claims correlate with abrasive performance and consumer perception.
- Anti-gingivitis/anti-plaque claims correlate with active exposure and preservative system that does not reduce performance.
Pack and stability interaction
- Tube vs. other pack types can affect headspace moisture ingress and flavor loss, which ties back to excipient moisture control and preservative performance.
Which commercial opportunities exist in contract manufacturing and private label using Colgate-grade excipient know-how?
Featured snippet: Contract manufacturers can win by building a “formula-to-spec” platform: validated abrasive dispersion, fluoride compatibility, and viscosity control packages that allow faster customization under a fixed process envelope.
Where contract leverage is highest
- Multi-SKU programs that share the same excipient backbone with different flavor systems or strength actives.
- Regions with volatile raw material pricing where dual sourcing and substitute qualification matter.
- Retail channel demand for consistent texture and suspension stability at the end of shelf life.
Winning deliverables
- Robust sedimentation stability data across temperature ranges.
- Flavor retention and sensory panel stability over time.
- Microbial challenge testing for each pack format and preservative system.
How do excipient choices compare across leading oral-care platforms (fluoride, whitening, sensitivity)?
Featured snippet: The biggest excipient differences show up in mineral compatibility (abrasive + buffers), rheology needs (gel vs paste), and sensory tolerance for sensitivity products.
Comparative formulation logic (high level)
| Platform goal | Typical excipient emphasis | Key risk |
|---|---|---|
| Fluoride anticaries | buffer/chelator balance + mineral compatibility + suspension stability | fluoride reduction via Ca/P interactions |
| Whitening/stain control | abrasive system selection + dispersion stability + humectant balance | abrasive settling or irritancy perception |
| Sensitivity | surfactant mildness + humectant comfort + polymer rheology | taste/foam changes and microbial stability |
What generic entry risks exist for excipients in Colgate-type oral-care?
Featured snippet: There is no Orange Book-style exclusivity model for excipients in mouth-care. The entry risk is usually commercial and regulatory: whether a substitute excipient package can meet performance specs and claim requirements, not whether it infringes excipient patents.
Where “infringement” can still matter
- If Colgate owns patents on a specific delivery system, combination, or manufacturing process, excipient substitutions can alter performance and shift claims while still leaving method/process components within the protected design.
- In most consumer oral-care categories, the dominant barrier to entry is formula performance equivalence and data package acceptance rather than excipient freedom-to-operate.
Key takeaways
- Excipient strategy in Colgate-type products is performance-led: rheology, abrasive dispersion, fluoride compatibility, flavor retention, and microbial control.
- The most actionable commercial opportunities are excipient supply risk reduction, cost-down via validated substitutions, and process-driven defensibility (mixing order, shear windows, dispersion QC).
- Differentiation that matters commercially is hard to copy when paired with manufacturing know-how and tight specifications for viscosity, sedimentation, fluoride stability, and in-pack microbial safety.
FAQs
- Which excipients most strongly affect toothpaste viscosity and abrasive suspension stability?
- How do formulators maintain fluoride bioavailability when using calcium-containing abrasives?
- What excipient attributes best predict flavor retention over shelf life in toothpaste tubes?
- How should preservative systems be selected to maintain microbial safety across different mouth-care pH ranges?
- What process controls most reduce batch variability in abrasive dispersion and mouthfeel?
References (APA)
- R. S. Shukla, A. R. Goyal, & S. K. Nema. (2011). Formulation and evaluation of toothpaste. Journal of Pharmacy Research.
- European Medicines Agency (EMA). (n.d.). Guidance documents on quality requirements for medicinal products (general principles relevant to formulation changes). EMA.
- U.S. Food and Drug Administration (FDA). (n.d.). Current Good Manufacturing Practice (CGMP) regulations and guidance (principles for formulation and process control). FDA.
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
Visit the Subscription Options page for details on plans and pricing.
ISSN: 2162-2639

Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Access the Complete Database
Deeper Knowledge, Faster
- Analyze global market entry opportunities
- Obtain formulation and manufacturing information
- Drug patents in 130+ countries